Supplier

ViaPharma s.r.o.

Value won

CZK 12.1m

Across 6 contracts won

A Czech Republic supplier, with 6 awarded contracts, most recently 6 months ago.

Czech Republic(inferred)

Value won

CZK 12.1m

Across 6 contracts won

Contract history

6 entries

Most recent
26 Feb 2026
6 months ago
Biggest
CZK 7.2m
Antiviral Medications for Systemic…
Average size
CZK 2m
Across 6 priced
Last 12 months
3
entries

Won · 6

Antibacterial Agents for Systemic UseCZK 2,350,000 · 26 Feb 2026 Dynamic Purchasing System for Medical SuppliesCZK 143,350 · 15 Dec 2025 Dynamic Purchasing System for Medical SuppliesCZK 913,052 · 6 Oct 2025 Supply of Fingolimod MedicationCZK 1,015,575 · 15 May 2025 Antiviral Medications for Systemic UseCZK 7,233,013 · 15 May 2025 Dynamic Purchasing System for Pharmaceutical SuppliesCZK 431,753 · 29 Apr 2025

Apr 25Jul 25Sept 25Dec 25Mar 26

Opportunities

Showing awarded · 7

AwardedHealthcare & MedicalCzech Republic

Antibacterial Agents for Systemic Use

This public procurement contract involves the regular supply of medicinal products for parenteral administration containing the active substance tigecycline (ATC group J01AA12). These products are intended for the treatment of patients in approved indications according to the Summary of Product Char

CZK 2,350,000INSTITUTE OF CLINICAL AND EXPERIMENTAL MEDICINE

Published 26 Feb 2026

AwardedHealthcare & MedicalCzech Republic

Dynamic Purchasing System for Medical Supplies

This public procurement opportunity involves the supply of medicinal products, nutritional supplements, and selected medical devices intended for use in the clinics and departments of Bulovka University Hospital. Suppliers are invited to participate in a dynamic purchasing system that aims to stream

CZK 143,350BULOVKA FACULTY HOSPITAL

Published 15 Dec 2025

AwardedHealthcare & MedicalCzech Republic

Dynamic Purchasing System for Medical Supplies

This public procurement contract involves the supply of medicinal products, nutritional supplements, and selected medical devices intended for use in the clinics and departments of Bulovka University Hospital. Suppliers are invited to participate in a dynamic purchasing system (DPS) to provide these

CZK 913,052BULOVKA FACULTY HOSPITAL

Published 6 Oct 2025

AwardedHealthcare & MedicalCzech Republic

Antiviral Medications for Systemic Use

This public procurement contract involves the ongoing supply of antiviral medications classified under ATC group J05A* for a duration of 4 years, based on the current needs of the contracting authority. The contract is valued at approximately 7,233,013 EUR and is aimed at supporting health services.

CZK 7,233,013FACULTY HOSPITAL HRADEC KRLOV

Published 15 May 2025

AwardedHealthcare & MedicalCzech Republic

Supply of Fingolimod Medication

This public procurement contract involves the ongoing supply of the medication containing the active ingredient fingolimod (ATC L04AE01). The specific product required is fingolimod in a dosage form of 0.5MG capsules, packaged in units of 28 capsules per box, with a total quantity of 3,300 boxes nee

CZK 1,015,575THOMAYER HOSPITAL

Published 15 May 2025

AwardedHealthcare & MedicalCzech Republic

Oxycodone Pain Relief Medications Supply Contract

This public procurement contract involves the ongoing supply of pharmaceutical products that meet the requirements set by the State Institute for Drug Control (SÚKL). The contract is valued at approximately 4,087,498.68 CZK and is intended for the health sector. The buyer is the Faculty Hospital in

CZK 4,087,499FACULTY HOSPITAL OLOMOUC

Published 6 May 2025

AwardedHealthcare & MedicalCzech Republic

Dynamic Purchasing System for Pharmaceutical Supplies

This public procurement contract involves the establishment of a dynamic purchasing system for the supply of pharmaceutical products to a hospital pharmacy. The contracting authority will issue specific public contracts based on its current needs, which may arise at unspecified intervals. Detailed i

CZK 431,753HOSPITAL NEW TOWN ON MORAVIA CONTRIBUTORY ORGANIZATION

Published 29 Apr 2025